-
4
-
-
0023189396
-
Pentoxifylline: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy
-
Ward A, Clissold SP: Pentoxifylline: A review of the pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy. Drug 34:50-97, 1987. (Pubitemid 17092322)
-
(1987)
Drugs
, vol.34
, Issue.1
, pp. 50-97
-
-
Ward, A.1
Clissold, S.P.2
-
5
-
-
0029068531
-
Hemorrheologic effects of metabolites of pentoxifylline
-
Ambrus JL, Stadler S, Kulaylat M: Hemorrheologic effects of metabolites of pentoxifylline. J Med 26(1-2): 65-75, 1995.
-
(1995)
J Med
, vol.26
, Issue.1-2
, pp. 65-75
-
-
Ambrus, J.L.1
Stadler, S.2
Kulaylat, M.3
-
6
-
-
79251510574
-
Dosing regimen and hematologic effects of pentoxifylline and its active metabolites in dogs
-
Rees CA, Boothe DM, Boeckh A, et al: Dosing regimen and hematologic effects of pentoxifylline and its active metabolites in dogs. Vet Ther 4(2):188-196, 2003.
-
(2003)
Vet Ther
, vol.4
, Issue.2
, pp. 188-196
-
-
Rees, C.A.1
Boothe, D.M.2
Boeckh, A.3
-
8
-
-
0022355254
-
Kinetics of intravenous and oral pentoxifylline in healthy subjects
-
Beerman B, Ings R, Mansby J, et al: Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther 37:25-28, 1985.
-
(1985)
Clin Pharmacol Ther
, vol.37
, pp. 25-28
-
-
Beerman, B.1
Ings, R.2
Mansby, J.3
-
9
-
-
0022657005
-
Determination of pentoxifylline and major metabolite 3,7 dimethyl 1 (5c hydroxyhexyl) xanthine by HPLC
-
Luke DR, Rocci ML: Determination of pentoxifylline and major metabolite 3,7 dimethyl 1 (5c hydroxyhexyl) xanthine by HPLC. J Chromatogr 374:191" 195, 1986.
-
(1986)
J Chromatogr
, vol.374
, pp. 191-195
-
-
Luke, D.R.1
Rocci, M.L.2
-
10
-
-
0021253301
-
Pharmacology of pentoxifylline, a hemorheologic agent for the treatment of intermittent claudication
-
Aviado DM, Dettelbach HR: Pharmacology of pentoxifylline, a hemorheologic agent for the treatment of intermittent claudication. Angiology 35:407-417, 1984.
-
(1984)
Angiology
, vol.35
, pp. 407-417
-
-
Aviado, D.M.1
Dettelbach, H.R.2
-
11
-
-
0022595673
-
Pharmacokinetics of orally administered pentoxifylline in humans
-
Smith RV, Waller ES, Doluisio JT, et al: Pharmacokinetics of orally administered pentoxifylline in humans. J Pharm Sci 75(1):47-52, 1986.
-
(1986)
J Pharm Sci
, vol.75
, Issue.1
, pp. 47-52
-
-
Smith, R.V.1
Waller, E.S.2
Doluisio, J.T.3
-
12
-
-
0007453261
-
Congenital and hereditary defects
-
in Scott DW, Miller WH, Griffin CE (eds), Philadelphia, WB, Saunders
-
Scott DW, Miller WH, Griffin CE: Congenital and hereditary defects, in Scott DW, Miller WH, Griffin CE (eds): Small Animal Dermatology. Philadelphia, WB Saunders, 2001, pp 940-946.
-
(2001)
Small Animal Dermatology.
, pp. 940-946
-
-
Scott, D.W.1
Miller, W.H.2
Griffin, C.E.3
-
13
-
-
0031501222
-
Use of pentoxifylline in the treatment of allergic contact dermatitis to plants of the Commelianaceae family in dogs
-
Marsella R, Kunkle GA, Lewis DT: Use of pentoxifylline in the treatment of allergic contact dermatitis to plants of the Commelianaceae family in dogs. Vet Dermatol 8(2):121"126, 1997.
-
(1997)
Vet Dermatol
, vol.8
, Issue.2
, pp. 121-126
-
-
Marsella, R.1
Kunkle, G.A.2
Lewis, D.T.3
-
14
-
-
79251477334
-
Pentoxifylline
-
Winter
-
Rees CA: Pentoxifylline. Derm Dialogue Winter 1999, pp 10-13.
-
(1999)
Derm Dialogue
, pp. 10-13
-
-
Rees, C.A.1
|